CAPTRUST FINANCIAL ADVISORS

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1512024 RALEIGH, NC

Position in PTGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$799,466

+$598,996 QoQ

Shares Held

6,522

+242.9% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#186

of 343 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 26% Shared 0% None 74%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. PTGX ranks #26 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,464	$22,736,762
2	RPRX	Royalty Pharma plc	337,298	$18,912,298
3	VRTX	Vertex Pharmaceuticals Inc / Ma	35,471	$17,619,509
4	EXEL	Exelixis, Inc.	303,042	$16,488,515
5	LGND	Ligand Pharmaceuticals Inc	34,607	$10,938,926
6	HALO	Halozyme Therapeutics, Inc.	125,946	$9,857,793
7	CELC	Celcuity Inc.	71,445	$7,474,575
8	INCY	Incyte Corp	50,301	$5,702,121

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$799,466	6,522	+242.9%	Shares	Sole	2026-08-13
2026-03-31	$200,470	1,902	-30.4%	Shares	Sole	2026-05-15
2025-12-31	$238,612	2,732	-17.5%	Shares	Sole	2026-02-17
2025-09-30	$220,016	3,312	-43.7%	Shares	Sole	2025-11-19
2024-12-31	$226,890	5,878	-4.0%	Shares	Sole	2025-02-14
2024-09-30	$275,670	6,126	-0.2%	Shares	Sole	2024-11-14
2024-06-30	$212,751	6,140	+432.5%	Shares	Sole	2024-08-15
2021-12-31	$39,432	1,153	+2581.4%	Shares	Sole	2022-02-14
2021-09-30	$761	43	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.